Hillsdale Investment Management Inc. Novo Nordisk A S Transaction History

Hillsdale Investment Management Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 22, 2021	SELL	$67.06 - $75.82 $9,388 - $10,614	-140 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$63.89 - $73.8 $1,916 - $2,214	-30 Reduced 17.65%	140 $10,000
Q3 2020 Nov 13, 2020	BUY	$63.69 - $70.22 $5,095 - $5,617	80 Added 88.89%	170 $12,000
Q2 2020 Aug 11, 2020	BUY	$58.54 - $67.94 $5,268 - $6,114	90 New	90 $6,000
Q4 2018 Feb 12, 2019	SELL	$41.54 - $47.25 $16,616 - $18,900	-400 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	400	400 $17,000

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

Stay updated on Hillsdale Investment Management Inc. with notifications on news.